BACKGROUND: The authors present their experience with rectal adenomas managed by transanal endoscopic microsurgery (TEM). The goals of this study were to examine our institution's experience by evaluating surgical morbidity, mortality, and local recurrence rate. METHODS: This retrospective study investigated 402 patients who underwent TEM a for preoperative diagnosis of adenoma from January 1993 to October 2008. The mean age was 65 years (range = 22-92 years). All patients were regularly followed up to determine treatment efficacy in terms of local recurrence rate. RESULTS: No 30-day perioperative mortality occurred. No conversion to laparoscopic or open procedures was reported. Minor complications occurred in 28 (7%) patients, whereas major complications were found only in 2 (0.5%) patients. Definitive histology confirmed adenomas in 366 cases (91%). At a mean follow-up of 84 months (range = 1-190 months), 16 (4%) adenomas recurred and were successfully retreated by TEM [14 cases (87.5%)] and by conventional surgery [2 patients (12.5%)]. No further recurrences were observed at subsequent follow-up. CONCLUSION: The findings warrant the conclusion that TEM is a safe, effective treatment for rectal adenomas where endoscopic removal is not applicable and has low morbidity and no mortality.
BACKGROUND: The authors present their experience with rectal adenomas managed by transanal endoscopic microsurgery (TEM). The goals of this study were to examine our institution's experience by evaluating surgical morbidity, mortality, and local recurrence rate. METHODS: This retrospective study investigated 402 patients who underwent TEM a for preoperative diagnosis of adenoma from January 1993 to October 2008. The mean age was 65 years (range = 22-92 years). All patients were regularly followed up to determine treatment efficacy in terms of local recurrence rate. RESULTS: No 30-day perioperative mortality occurred. No conversion to laparoscopic or open procedures was reported. Minor complications occurred in 28 (7%) patients, whereas major complications were found only in 2 (0.5%) patients. Definitive histology confirmed adenomas in 366 cases (91%). At a mean follow-up of 84 months (range = 1-190 months), 16 (4%) adenomas recurred and were successfully retreated by TEM [14 cases (87.5%)] and by conventional surgery [2 patients (12.5%)]. No further recurrences were observed at subsequent follow-up. CONCLUSION: The findings warrant the conclusion that TEM is a safe, effective treatment for rectal adenomas where endoscopic removal is not applicable and has low morbidity and no mortality.
Authors: M Guerrieri; F Feliciotti; M Baldarelli; P Zenobi; A De Sanctis; G Lezoche; E Lezoche Journal: Dig Liver Dis Date: 2003-12 Impact factor: 4.088
Authors: Hemanga K Bhattacharjee; Gerhard F Buess; Francisco Cesar Becerra Garcia; Pirmin Storz; Mousumi Sharma; Sidonia Susanu; Andreas Kirschniak; Mahesh C Misra Journal: Surg Endosc Date: 2010-12-07 Impact factor: 4.584
Authors: Elisabeth C McLemore; Christina R Harnsberger; Ryan C Broderick; Hyuma Leland; Patricia Sylla; Alisa M Coker; Hans F Fuchs; Garth R Jacobsen; Bryan Sandler; Vikram Attaluri; Anna T Tsay; Steven D Wexner; Mark A Talamini; Santiago Horgan Journal: Surg Endosc Date: 2015-12-10 Impact factor: 4.584
Authors: Sophie S F Hon; Simon S M Ng; Philip W Y Chiu; Francis K L Chan; Enders K W Ng; Jimmy C M Li; Janet F Y Lee; K L Leung Journal: Surg Endosc Date: 2011-07-26 Impact factor: 4.584
Authors: Elisabeth C McLemore; Alisa M Coker; Bikash Devaraj; Jeffrey Chakedis; Ali Maawy; Tazo Inui; Mark A Talamini; Santiago Horgan; Michael R Peterson; Patricia Sylla; Sonia Ramamoorthy Journal: Surg Endosc Date: 2013-03-14 Impact factor: 4.584